Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 2Recruiting 1Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Breast Neoplasms 181Colorectal Neoplasms 144Stomach Neoplasms 90Rectal Neoplasms 90Pancreatic Neoplasms 74Neoplasm Metastasis 60Neoplasms 48Colonic Neoplasms 40Esophageal Neoplasms 31Gallbladder Neoplasms 18Biliary Tract Neoplasms 17Bile Duct Neoplasms 17Carcinoma, Hepatocellular 15Triple Negative Breast Neoplasms 13Cholangiocarcinoma 12Adenocarcinoma 12Unspecified Adult Solid Tumor, Protocol Specific 11Parkinson Disease 4, Autosomal Dominant Lewy Body 11Liver Neoplasms 10Breast Neoplasms, Male 10Adenocarcinoma Of Esophagus 10Squamous Cell Carcinoma of Head and Neck 9Head and Neck Neoplasms 9Gastrointestinal Neoplasms 9Carcinoma, Renal Cell 8Carcinoma, Non-Small-Cell Lung 8Brain Neoplasms 7Prostatic Neoplasms 6Ovarian Neoplasms 6Uterine Cervical Neoplasms 5

Interventions

Sunitinib 4Everolimus 4Fluorouracil 3Temozolomide 2Streptozocin 2Octreotide 2Leucovorin 2Irinotecan 2sargramostim 1sapanisertib 1pasireotide 1napabucasin 1motesanib diphosphate 1montanide ISA 51 1irinotecan sucrosofate 1incomplete Freund's adjuvant 1ibrutinib 1ganitumab 1cabozantinib 1batifiban 1aflibercept 1Wound Healing 1Thalidomide 1Taxes 1Sorafenib 1Salts 1Plastic Surgery Procedures 1Paclitaxel 1Oxaliplatin 1Melphalan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Adenoma, Islet Cell × Capecitabine × Clear all
NCT00602082 2013-08-07

Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine Tumors

National Cancer Institute (NCI)

Phase 2 Completed
84 enrolled
Endocrine

Glucagonoma, Insulinoma, Adenoma, Islet Cell, Somatostatinoma, Gastrinoma, Carcinoma, Islet Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡